Results of phase I pharmacokinetic and pharmacodynamic studies of the Raf kinase inhibitor BAY 43-9006 in patients with solid tumors
Strumberg, D, Voliotis, D, Moeller, J G, Hilger, R A, Richly, H, Kredtke, S, Beling, C, Scheulen, M E, Seeber, S
Published in International journal of clinical pharmacology and therapeutics (01.12.2002)
Published in International journal of clinical pharmacology and therapeutics (01.12.2002)
Get more information
Journal Article
Pharmacokinetics of moxifloxacin are not influenced by a 7-day pretreatment with 200 mg oral itraconazole given once a day in healthy subjects
Stass, H, Nagelschmitz, J, Moeller, J G, Delesen, H
Published in International journal of clinical pharmacology and therapeutics (01.01.2004)
Published in International journal of clinical pharmacology and therapeutics (01.01.2004)
Get more information
Journal Article
ERK1/2 phosphorylation: a biomarker analysis within a phase I study with the new Raf kinase inhibitor BAY43-9006
Hilger, R A, Kredke, S, Hedley, D, Moeller, J G, Bauer, R J, Stellberg, W, Seeber, S, Scheulen, M E, Strumberg, D
Published in International journal of clinical pharmacology and therapeutics (01.12.2002)
Published in International journal of clinical pharmacology and therapeutics (01.12.2002)
Get more information
Journal Article